These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 17107242)
1. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145 [TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial. English BA; Jewell M; Jewell G; Ambrose S; Davis LL J Clin Psychopharmacol; 2006 Feb; 26(1):84-8. PubMed ID: 16415713 [TBL] [Abstract][Full Text] [Related]
4. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related]
5. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045 [TBL] [Abstract][Full Text] [Related]
7. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
8. An open-label assessment of aripiprazole in the treatment of PTSD. Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652 [TBL] [Abstract][Full Text] [Related]
9. Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. Seedat S; Stein DJ; Ziervogel C; Middleton T; Kaminer D; Emsley RA; Rossouw W J Child Adolesc Psychopharmacol; 2002; 12(1):37-46. PubMed ID: 12014594 [TBL] [Abstract][Full Text] [Related]
10. A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo. Rothbaum BO; Davidson JR; Stein DJ; Pedersen R; Musgnung J; Tian XW; Ahmed S; Baldwin DS J Clin Psychiatry; 2008 Oct; 69(10):1529-39. PubMed ID: 19192435 [TBL] [Abstract][Full Text] [Related]
11. Duloxetine in military posttraumatic stress disorder. Villarreal G; Cañive JM; Calais LA; Toney G; Smith AK Psychopharmacol Bull; 2010; 43(3):26-34. PubMed ID: 21150844 [TBL] [Abstract][Full Text] [Related]
12. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population. Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753 [TBL] [Abstract][Full Text] [Related]
13. [Escitalopram for treatment of major depressive disorder in adults]. Llorca PM; Brousse G; Schwan R Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716 [TBL] [Abstract][Full Text] [Related]
16. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression. Miner CM; Brown EB; Gonzales JS; Munir R J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723 [TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. Escalona R; Canive JM; Calais LA; Davidson JR Depress Anxiety; 2002; 15(1):29-33. PubMed ID: 11816050 [TBL] [Abstract][Full Text] [Related]
18. Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial. Suliman S; Seedat S; Pingo J; Sutherland T; Zohar J; Stein DJ BMC Psychiatry; 2015 Feb; 15():24. PubMed ID: 25885650 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. Pelissolo A Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243 [TBL] [Abstract][Full Text] [Related]
20. Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind Trial. Zohar J; Fostick L; Juven-Wetzler A; Kaplan Z; Shalev H; Schreiber G; Miroshnik N; Shalev AY; Stein DJ; Seedat S; Suliman S; Klein E J Clin Psychiatry; 2018; 79(2):. PubMed ID: 28703951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]